Humanized CAR-T Therapy for Treatment of B Cell Malignancy

NCT02782351 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

BIOLOGICAL: CAR-T

Sponsor

Kai Lin Xu; Jun Nian Zheng

Collaborators

[object Object]
[object Object]